These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Urinary diversion during and after pediatric pyeloplasty: a population based analysis of more than 2,000 patients. Sturm RM; Chandrasekar T; Durbin-Johnson B; Kurzrock EA J Urol; 2014 Jul; 192(1):214-9. PubMed ID: 24518773 [TBL] [Abstract][Full Text] [Related]
15. Conversion of percutaneous ureteral stent to indwelling pigtail stent over guidewire. Bigongiari LR; Lee KR; Moffat RE; Mebust WK; Foret J; Weigel J Urology; 1980 May; 15(5):461-5. PubMed ID: 6189275 [TBL] [Abstract][Full Text] [Related]
16. Extracorporeal urinary bypass for malignant ureteral obstruction. Tomooka Y; Yokoyama M; Takeuchi M Urology; 1994 Jun; 43(6):878-9. PubMed ID: 8197655 [TBL] [Abstract][Full Text] [Related]
17. Subcutaneous urinary diversion utilizing a nephrovesical stent: a superior alternative to long-term external drainage? Nakada SY; Gerber AJ; Wolf JS; Hicks ME; Picus D; Clayman RV Urology; 1995 Mar; 45(3):538-41. PubMed ID: 7879349 [TBL] [Abstract][Full Text] [Related]
18. Nephro-ileal conduit subcutaneous stent: an alternative to percutaneous nephrostomy. Leonardo C; Rondoni M; Meneschincheri F; Peris F; Leonardo F; De Nunzio C Minerva Urol Nefrol; 2006 Sep; 58(3):165-7. PubMed ID: 17124487 [TBL] [Abstract][Full Text] [Related]
19. Management of ureteral obstruction due to advanced malignancy: optimizing therapeutic and palliative outcomes. Kouba E; Wallen EM; Pruthi RS J Urol; 2008 Aug; 180(2):444-50. PubMed ID: 18550089 [TBL] [Abstract][Full Text] [Related]
20. Management of extrinsic malignant ureteral obstruction with urinary diversion. Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]